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Korean Red Ginseng (KRG) exerts chemopreventive effects on experimentally induced carcinogenesis
through multiple mechanisms. In this study, we investigated effects of KRG on dextran sulfate sodium
(DSS)-induced colitis and azoxymethane (AOM) plus DSS-induced colon carcinogenesis in mice. Male
C57BL/6J mice were fed diet containing 1% KRG or a standard diet throughout the experiment. The mouse
colitis was induced by administration of 3% DSS in drinking water for 1 week. DSS caused body weight
loss, diarrhea, rectal bleeding and colon length shortening, and all these symptoms were ameliorated by
KRG treatment. KRG inhibited DSS-induced expression of cyclooxygenase-2 (COX-2) and inducible nitric
oxide synthase (iNOS) by suppressing activation of nuclear factor-kappa B (NF-kB) and signal transducer
and activation of transcription 3 (STAT3). In another experiment, colon carcinogenesis was initiated by
single intraperitoneal injection of AOM (10 mg/kg) and promoted by 2% DSS in drinking water. KRG
administration relieved the symptoms of colitis and reduced the incidence, the multiplicity and the size
of colon tumor. The up-regulation of COX-2, iNOS, c-Myc and Cyclin D1 by AOM plus DSS was attenuated
in KRG fed mice which was associated with suppression of NF-kB and STAT3 activation. These results
suggest that KRG is a potential candidate for chemoprevention of inflammation-associated cancer in the
colon.
© 2020 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Inflammation arises from microbial infection or noninfective
physical/chemical irritation. In general, acute (physiologic)
inflammation is self-limiting as seen in wound healing. Failure in
resolving the acute inflammation may cause chronic inflammation
implicated in pathogenesis of many human disorders.1 Multipler Medicine and Biopharma-
ience and Technology, Seoul
for Food and Biomolecules,
National Taiwan University. Produc
es/by-nc-nd/4.0/).lines of evidence from clinical, epidemiologic, genetic and phar-
macological data support the association between inflammation
and cancer.2e5 It becomes increasingly evident that the tumor
microenvironment is largely orchestrated by immune and inflam-
matory cells surrounding cancer cells, and inflammatory microen-
vironment is indispensable for the neoplastic process.3e7
The connection between inflammation and tumorigenesis has
been well established in both heritable and sporadic forms of
colorectal cancer (CRC). Inflammatory bowel disease (IBD), such as
Crohn’s disease and ulcerative colitis, is an important risk factor for
the CRC.8 Thus, patients with long-standing IBD have an increased
risk of developing CRC than general population.9,10 Distinct cyto-
kines, chemokines and other proinflammatory mediators produced
by immune cells are involved in virtually all steps of CRCtion and hosting by Elsevier Taiwan LLC. This is an open access article under the CC
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Cyclooxygenase-2 (COX-2), a rate-limiting enzyme in the
arachidonic acid cascade, is consistently overexpressed in inflamed
tissues. This enzyme converts arachidonic acid to prostaglandin H2
which is further converted to prostaglandin E2 (PGE2). NF-kB is a
major transcription factor that regulates expression of prototypic
pro-inflammatory enzymes, COX-2 and inducible nitric oxide syn-
thase (iNOS). NF-kB is sequestered in the cytoplasm by IkBa in
resting cells. Activation of NF-kB is dependent on degradation of
IkBa through phosphorylation and ubiquitination. This liberates
NF-kB in an active form, mainly as p65/p50 heterodimer, which
migrates into the nucleus. p65 also undergoes phosphorylation
which facilitates its nuclear translocation and recruitment of
coactivators including p300/CBP, thereby regulating the expression
of multiple target genes.12 STAT3 is another key transcription factor
involved in inflammation and immunity.13 STAT3 is activated
through phosphorylation at the tyrosine 705 (Tyr705) residue. The
phosphorylated STAT3, in turn, dimerizes and translocates to the
nucleus, where it directly regulates target gene expression.13
Persistent activation of NF-kB and STAT3 is implicated in
inflammation-associated carcinogenesis. The interaction and
cooperation between these two transcription factors play vital roles
in controlling the communication between cancer cells and in-
flammatory cells. Understanding the molecular mechanisms of NF-
kB and STAT3 cooperation in cancer will offer opportunities for the
successful implementation of chemopreventive and chemothera-
peutic approaches.14
Korean ginseng (Panax ginseng C.A. Meyer) has been used as a
medicinal herb for thousands of years. One way to process raw
ginseng is steaming and drying to generate red ginseng. Korean red
ginseng (KRG) is known for its beneficial effects on immunity,
improvement of cognitive function, amelioration of fatigue, cancer
survival, etc. The active components of KRG include saponins
(ginsenosides), polysaccharides, and fatty acids. Prolonged admin-
istration of KRG has been known to have cancer preventive ef-
fects.15 However, molecular mechanisms responsible for its
chemopreventive effects remain still to be clarified.
In this study, we have investigated the effects of KRG on dextran
sulfated sodium (DSS)-induced colitis and azoxymethane (AOM)
plus DSS-induced colon carcinogenesis in C57BL/6J mice which
mimic human IBD and inflammation-associated CRC, respectively.
2. Materials and methods
2.1. Materials
DSS with an average molecular weight of 36,000e50,000 was
purchased from MP Biomedicals, LLC (Solon, OH, USA). AOM was
obtained from Sigma-Aldrich (St Louis, MO, USA). Standardized
KRG powder was supplied by Korea Ginseng Corporation (Seoul,
South Korea). COX-2 (murine) polyclonal antibody produced from
rabbit was supplied by Cayman Chemical (Ann Arbor, MI, USA).
Polyclonal rabbit anti-iNOS antibody was provided by BD Bio-
sciences (Franklin Lakes, NJ, USA). Primary antibodies against Cyclin
D1, STAT3, p-STAT3 (Tyr705), p65 and p-IkBa (Ser32) were offered
by Cell Signaling Technology, Inc. (Danvers, MA, USA). Antibodies
against p-p65 (Ser536) and IkBa were obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA, USA). Antibody against lamin B1
was obtained from Invitrogen Corporation (Camarillo, CA, USA).
Antibodies against actin and a-tubulin were bought from AbClon,
Inc. (Seoul, South Korea). Horseradish peroxidase-conjugated anti-
mouse and rabbit secondary antibodies were obtained from Zymed
lavoratories (San Fransico, CA, USA). An NF-kB oligonucleotide
probe containing the consensus sequence (50-AGT TGA GGG GAC
TTT CCC AGG C-30, 30-TCA ACT CCC CTG AAA GGG TCC G-50) waspurchased from Promega (Madison, WI, USA). EPD and pico EPD
Western blot detection kit were products of ELPISBIOTECH, Inc.
(Daejeon, South Korea). All other chemicals used in our experi-
ments were of the purest grade available from regular commercial
sources.
2.2. Animal treatment
All the animal experiments were performed according to the
approved guidelines of the Seoul National University (SNU-120629-
1). Four-week-old male C57BL/6J mice were obtained from Central
Lab Animal (Seoul, South Korea) and maintained on conventional
housing conditions. After an acclimation for 7 days, mice were
divided into groups as illustrated in Supplementary Fig. 1 and fed
control or experimental diet throughout the experiment. Compo-
sition of experimental diet and content of ginsenosides of KRG are
shown in Supplementary Tables S1 and S2, respectively.
For a short-term experiment to induce colitis, mice in the con-
trol group and the DSS group received the control diet. Mice in the
DSS plus KRG group and the KRG alone group received control diet
supplemented with 1% (w/w) KRG powder during the entire period
of the experiment. DSS (3%, w/v) in drinking water was given for 1
week. To induce CRC formation, mice were given single intraperi-
toneal (i.p.) injection of AOM (10 mg/kg body weight) followed by
oneweek later exposure to 2% DSS in drinking water for 7 days, and
then kept without any further treatment for 14 weeks. Mice in the
control group and the AOM plus DSS group received control diet,
and mice in the AOM þ DSS þ KRG group received control diet
supplemented with 1% KRG powder.
2.3. Macroscopic assessment
During 7 days of DSS treatment, the body weight of mice was
measured every day. Rectal bleeding and stool consistency were
monitored and scored from 0 to 3 in a modified design depending
on the severity of blood and diarrhea. Disease activity index (DAI)
was determined as the sum of scores of rectal bleeding and stool
consistency. In the long-term tumor experiment, collected colon
tissues were cut longitudinally and the tumors were identified.
After the measurement of the number and the size of tumors, they
were excised, collected and weighed.
2.4. Histological examination
Specimens of distal parts of the colon were fixed with 10%
phosphate buffered formalin, embedded in paraffin and stained
with hematoxylin and eosin (H&E).
2.5. Western blot analysis
Mouse colon parts were cut longitudinally, and washed with
phosphate-buffered saline (PBS), and stored at 70 C until use.
Colon tissue was homogenized in the lysis buffer [1 mM phenyl-
methylsulfonylfluoride (PMSF) and EDTA-free protease inhibitor
cocktail tablet] followed by periodical vortex mixing for 2 h. Lysates
were centrifuged at 13,000 rpm for 15 min at 4 C. Supernatants
were collected and stored at 70 C. The total protein concentra-
tion was quantified using a bicinchoninic acid protein assay kit
(Pierce Biotechnology). After mixing and heating with sodium
dodecyl sulfate (SDS) buffer, 20e30 mg of whole protein lysate was
separated by SDS-PAGE and transferred to polyvinyliden difluoride
membrane at 300 mA for 3 h. The blots were blocked in 5% skim
milk in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 h at
room temperature and incubated with primary antibodies in TBST
at 4 C overnight. Blots were thenwashed with TBST for 30min and
Fig. 1. Effects of KRG on experimentally induced colitis. Effects of KRG on the body weight change (A), DAI (B) and the colon length (C) in mice exposed to 3% DSS in drinking
water for 1 week. (D) Microscopic examination of H&E stained colonic mucosa from control mice and those treated with 3% DSS alone for 1 week, 3% DSS plus 1% dietary KRG and
KRG alone. Results are presented as means ± SD. *p < 0.05, **p < 0.01, and ***p < 0.001.
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body in TBST for 1 h at room temperature. Blots were washed again
three times, and transferred proteins were visualized with an
enhanced chemiluminescence detection kit and the LAS-4000 im-
age reader according to the manufacturer’s instructions.
2.6. Fractionation of nuclear and cytoplasmic extracts
Nuclear and cytoplasmic extracts of colonic tissues were pre-
pared according to the standard method. Briefly, colon tissue was
homogenized in hypotonic buffer A [10mMHEPES (pH 7.8), 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM dithiothreitol (DTT), 0.2 mM PMSF] and
incubated for 1 h on ice, and 0.1% NP-40 was added right before
centrifugation. After centrifugation at 13,000 rpm for 15 min at
4 C, the supernatants containing the cytoplasmic extract were
collected and stored at 70 C. Precipitated pellets were washed
with buffer A for 2 times to remove remaining cytoplasmic com-
ponents. Then pellets were re-suspended in buffer C [20mMHEPES
(pH 7.8), 20% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM eth-
ylenediaminetetraacetic acid (EDTA), 0.5 mM DTT, 0.2 mM PMSF]
and incubated on ice for 1 h with vortex mixing at 5 min interval.
After centrifugation at 13,000 rpm for 15 min at 4 C, the super-
natants (the nuclear extract) were collected and stored at 70 C.2.7. Electrophoresis mobility shift assay (EMSA)
The DNA binding activity of NF-kB was measured with EMSA
using a DNA binding detection kit according to manufacturer’s
protocol (Gibco BRL; Grand island, NY, USA). T4 polynucleotide
kinase catalyzes the transfer and exchange of the phosphate group
from the g-position of ATP to the 50ehydroxyl terminus of the NF-
kB oligonucleotide. After purification with a G-50 micro column.
The [g-32P]-labeled probe was mixed with 10 mg of nuclear extracts
and incubation buffer [10 mM Tris-HCl (pH 7.5), 100 mM NaCl,
1mMDTT,1mMEDTA, 4% glycerol and 0.1mg/ml sonicated salmon
sperm DNA]. All the samples were mixed with 2 ml 0.1% bromo-
phenol blue loading dye after 50-min incubation and separated on
6% non-denatured polyacrylamide gel in a cold room. Finally, gels
were dried and exposed to X-ray films.2.8. Statistics
All values were expressed as the mean ± SD or the mean ± SE
according to data type. Statistical significance was determined by
the Student’s t-test and p < 0.05 was considered to be statistically
significant.
Fig. 2. Inhibition of DSS-induced expression COX-2 and iNOS by KRG in mouse
colon. All mice were killed after 7 days of DSS exposure, and colon tissue was
collected. Colon was cut longitudinally and divided equally. Expression of COX-2 and
iNOS was measured by Western blot analysis as described in Materials and methods.
Results are presented as means ± SE. *p < 0.05, **p < 0.01, and ***p < 0.001.
Fig. 3. Inhibitory effects of KRG on DSS-induced IkBa phosphorylation and
degradation. (A) Effects of KRG on DSS-induced IkBa phosphorylation were deter-
mined by Western blot analysis using cytoplasmic extracts. (B) Effects of KRG on DSS-
induced IkBa degradation were determined by Western blot analysis. Results are
presented as means ± SE. *p < 0.05 and ***p < 0.001.
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3.1. Effects of KRG on DSS-induced colitis in mice
DSS is a high molecular weight sulfated polysaccharidecommonly used in animal models for inducing acute and chronic
colitis.16 DSS increases the colonic mucosal permeability and acti-
vates inflammatory signaling pathways.17 From the 4th day of 3%
DSS exposure, the body weight of mice became significantly
decreased compared to the control group. KRG treatment inhibited
body weight loss caused by DSS administration (Fig. 1A). DAI was
scored according to the severity of bleeding and stool consistency.
The DAI score of mice in the DSS plus KRG group was significantly
lower than that of mice in the DSS only group (Fig. 1B). Moreover,
DSS exposure for 7 days shortened the colon length of mice, and
KRG treatment partially restored it (Fig. 1C). H&E staining of distal
colon revealed that DSS administration resulted in colitis exhibiting
epithelial degeneration, crypt loss and inflammatory cell infiltra-
tion. Dietary administration of KRG attenuated DSS-induced
colonic mucosal damage (Fig. 1D).
3.2. Effects of KRG on DSS-induced inflammatory signaling
COX-2 and iNOS are prototypic pro-inflammatory enzymes
which are often overexpressed in inflammatory conditions. The
Western blot analysis of colon revealed that DSS induced over-
expression of COX-2 and iNOS, which was significantly reduced by
KRG (Fig. 2).
NF-kB is a principal transcription factor responsible for regu-
lating the expression of many signaling molecules involved in
inflammation and cell survival. DSS administration activated NF-kB
signaling through blockage of phosphorylation (Fig. 3A) and
degradation (Fig. 3B) of IkBa, an inhibitory protein that sequesters
NF-kB in the cytoplasm. p65 is a functionally active subunit of NF-
kB. Phosphorylation of p65 facilitates its nuclear localization and
interaction with the co-activator, p300/CBP. Phosphorylation
(Fig. 4A) and nuclear accumulation (Fig. 4B) of p65 were markedly
increased in the colon of DSS-treated mice, and both events were
abolished by KRG supplementation in the diet (Fig. 4A and B).
Further, we found that DSS-induced colonic DNA binding activity of
NF-kB measured by the gel-shift assay was significantly reduced in
the KRG-fed group (Fig. 4C).
3.3. Effects of KRG on AOM plus and DSS-induced colitis and colon
carcinogenesis
DSS-induced colitis is necessary, but not sufficient to induce
tumor formation in mouse colon. In order to determine whether
KRG could prevent the colitis-associated carcinogenesis, we con-
ducted a long-term experiment in which mice were given a single
i.p. administration of the carcinogen, AOM followed by 2% DSS
treatment for 1 week. During 7 days of DSS exposure, the body
weight and the DAI of mice in each group were checked. Dietary
supplementation of KRG ameliorated the severity of colitis as well
as well as body weight loss caused by DSS (Supplementary Fig. 2).
Combining the systemic administration of AOM with DSS in
drinking water facilitates the formation of multiple colon tumors.18
Mice were sacrificed 16 weeks after the AOM injection. The colonic
mucosa of mice given AOM and DSS showed epithelial thickening,
hyperplasia and dysplasia (Fig. 5A), and these changes were
ameliorated by KRG supplementation in the diet. All mice in the
AOM plus DSS group developed colon tumors (Fig. 5B). However,
mice fed KRG containing diet had a much lower incidence (Fig. 5C)
and multiplicity (Fig. 5D) as well as the notably reduced volume
(Fig. 5E) of colonic tumors.
3.4. Effects of KRG on the inflammatory and proliferative signaling
in the colon of mice treated with AOM and DSS
Aberrant upregulation of COX-2 is known to promote CRC. The
Fig. 4. Inhibitory effects of KRG on DSS-induced phosphorylation, nuclear accumulation and DNA binding of NF-kB/p65. Phosphorylation (A) and nuclear accumulation (B) of
NF-kB p65 were determined byWestern blot analysis. NF-kB-DNA binding activity (C) was determined by EMSA. Incubation conditions and other experimental details are described
in Materials and methods. Results are presented as means ± SE. *p < 0.05, **p < 0.01 and ***p < 0.001.
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with AOM and DSS, and this was abolished by KRG supplementa-
tion (Fig. 6A). c-Myc and Cyclin D1 are representative oncogenic
proteins that stimulate cell proliferation. In tumor-free region of
colon in the AOM plus DSS group, expression of these proteins was
significantly up-regulated compared to the control group, which
was suppressed by KRG (Fig. 6A).
NF-kB and STAT3 play a vital role in inflammation-associated
carcinogenesis by upregulating the proinflammatory gene tran-
scription. Colons of the mice in the AOM plus DSS group showed
persistent activation of NF-kB and STAT3 as evidenced by phos-
phorylation of IkBa (Fig. 6B) with subsequent nuclear accumulation
of NF-kB/p65 and nuclear accumulation of p-STAT3 (Fig. 6B),
respectively. Dietary administration of KRG inhibited all these
events.4. Discussion
Chronic inflammation is closely related to the pathogenesis of
many different types of malignancies.1e7 Inflammatory cells,
including macrophages and neutrophils, secrete various signaling
molecules such as chemokines and cytokines that activate NF-kB
and STAT3 in epithelial cells. Chronically inflamed colonic tissues
have constitutive activation of these two key proinflammatory
transcription factors which upregulate expression of oncogenic
proteins, such as COX-2 and c-Myc, respectively. This creates in-
flammatory microenvironment favourable for tumor development
and progression.19 Therefore, inhibition of chronic inflammation is
considered to be a practical way to prevent cancer.
KRG has been known for its preventive effects on development
of various cancers.20 However, molecular mechanisms underlying
Fig. 5. Effects of KRG on AOM plus DSS-induced colonic tumorigenesis in mice. Mice were fed standard or 1% KRG diet for 17 weeks, starting 1 week before the single i.p.
injection of AOM (10 mg/kg) followed by exposure to 2% DSS for 7 days. (A) H&E stained colonic tissues of control mouse and those treated with AOM and DSS with and without
dietary KRG supplementation. (B) Macroscopic examination of mouse colon. Dietary administration of KRG inhibited colitis-induced carcinogenesis. The incidence (C), the number
(D) and the total weight (E) of colon tumor were assessed. Results are presented as means ± SD. *p < 0.05.
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study, we investigated effects of KRG on colitis and colitis-
associated colon carcinogenesis in mice. It has been reported that
American ginseng has anti-inflammatory effects on experimentally
induced mouse colitis which is associated with suppression of key
inflammatory markers such as COX-2 and iNOS.21,22 Our results
showed that KRG ameliorated DSS-induced colitis through down-
regulation of COX-2 and iNOS and blockage of NF-kB signaling
responsible for regulating these proinflammatory enzymes.
There appears to be a close interrelationship between COX-2
and iNOS and their products in inducing colitis and colitis-
induced cancer. PGE2, a major catalytic product of COX-2, affects
the biosynthesis of iNOS by modulating the expression/catalyticactivity of iNOS, whereas nitric oxide (NO) synthesized by iNOS
influences COX-2 expression/activity andconsequently, the syn-
thesis of PGE2.23 Therefore, combined blockage of COX-2 and iNOS
would provide a more efficient strategy than suppression of each
enzyme alone in dietary or pharmacological intervention of IBD
and inflammation-associated CRC. It will be of interest to examine
the profile of PGE2 and NO following intake of KRG in the context of
its impact on coordinated regulation of NF-kB-COX-2/PGE2-iNOS/
NO axis.
Of the numerous ingredients of KRG, saponins (ginsenosides)
are potent candidates that exert anti-inflammatory effects.24e26 A
panaxadiol-type ginsenoside, Rg3 inhibited expression of inflam-
matory mediators in mouse skin challenged with the tumor
Fig. 6. Inhibitory effects of KRG on AOM plus DSS-induced up-regulation of and inflammation and proliferation marker proteins and their regulators. Whole colons were
collected. After excision of all visible tumors, remaining colon tissue was subject to Western blot analysis for the measurement of inflammatory and proliferative protein markers (A)
and their upstream regulators (B). Animal treatment and other experimental details are described in Materials and methods. Results are presented as means ± SE. *p < 0.05,
**p < 0.01, and ***p < 0.001.
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Another type of ginsenosides, 20(S)-protopanaxatriol, inhibited
the expression of COX-2 and iNOS through inactivation of NF-kB in
LPS-stimulated macrophages.29 Based on these findings, ginseno-
sides are most likely be the main components of KRG responsible
for the inhibition of mouse colitis. Ginsenosides have structural
similarity to steroids.30 Thus, ginsenosides contained in KRG could
bind to and consequently activate a specific steroid receptor, which
may account for the preventive effects of KRG on DSS-induced
colitis.Besides ginsenosides, other ingredients of red ginseng have
health beneficial effects. Red ginseng oil (RGO) containing linoleic
acid and b-sitosterol as main bioactive components has been
shown to inhibit AOM plus DSS-induced colitis.31 Oral adminis-
tration of RGO reduced the plasma NO concentration and inhibited
the production of proinflammatory factors such as COX-2, iNOS,
interleukin-1b, interleukin-6, and tumor necrosis factor-a in the
mouse colitis tissue. Phosphorylation of p65 and IkB in the colon of
AOM and DSS treated mice was also attenuated by RGO adminis-
tration.31 In line with this notion, the hexane fraction of American
Fig. 7. Molecular mechanisms by which KRG inhibits experimentally induced colitis
and CRC formation.
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suppressed DSS-induced murine colitis and AOM-initiated and
DSS-promoted intestinal carcinogenesis.22
Colon is exposed to a vast variety of environmental factors that
can influence the intestinal microbiome. IBD is considered to result
from an exaggerated immune response, triggered by environ-
mental insults towards the altered gut microbiota.32 Thus, imbal-
ance of enterobacteria provokes host immune responses33 and
induces colitis in rats and mice.34 DSS-induced colitis begins with
the penetration of luminal bacteria into colon epithelium.35
Recently, probiotics have attracted public interest because of
their effective capability of promoting the balance of gut microbiota
as well as protecting the intestinal mucosa and strengthening the
intestinal barrier. It has been reported that supplement of pro-
biotics ameliorates experimental colitis by restoring/maintaining a
balance in the microbial environment in mouse colon.36 Dietary
ginseng has been reported to alter the colonic microbial diversity.37
Thus, extracts of Panax ginseng inhibited the growth of the harmful
bacteria, clostria while enhancing the growth of the Bifidobactierum
spp., a prototypic probiotic organism in vitro.38 Results from animal
experiments suggest that saponins can suppress intestinal
inflammation, promote intestinal barrier repair, maintain the di-
versity of the intestinal flora, and decrease the incidence rate of
inflammation-associated colon cancer.39 After treatment with AOM
and DSS, gut microbiota and metabolomic profiles were obviously
changed. Ginseng inhibited these changes, which may account for
its protection against colitis-associated carcinogenesis.40 Therefore,
the beneficial effects of KRG on the intestinal microflora may also
contribute to mitigation of DSS-induced colonic inflammation
processes and colitis-associated CRC.
The saponin components of ginseng taken orally undergo
metabolism by gut microflora, including those with probiotic
characteristics (e.g., Bifidobacterium spp., Lactobacillus spp., and
Saccharomyces spp.). Considering that the resulting metabolitesexert the main pharmacological activities of ginseng, its efficacy
after oral administration varies among individuals, depending on
their microbiome status. KRG extract fermented with Bifidobacte-
rium longum H-1 had anticolitic effects in two experimentally
induced murine colitis models.41 Further, oral administration of
KRG powder fermented with Lactobacillus plantarum alleviated
DSS-induced colitis to a greater extent than that achieved with oral
administration of ginseng powder or the probiotics alone.42
Compound K (20-O-b-D-glucopyranosyl-20(S)-protopanaxadiol)
is an enteric gut microbiome metabolite of Rb1. The treatment with
the antibiotic metronidazole reduced the serum levels of Com-
pound K following oral administration of ginseng.37 Compound K is
more efficiently absorbed into the systemic circulation and pos-
sesses stronger cancer chemopreventive potential than its parent
ginsenoside. Likewise, the gut microbial metabolite compound K
showed significant anti-inflammatory effects even at low concen-
trations, compared to its parent ginsenoside Rb1. Intestinal micro-
bial metabolites of American ginseng also significantly reduced
chemically-induced colitis, possibly through inhibition of pro-
inflammatory cytokine expression.43 Likewise, Compound K
ameliorated DSS-induced colitis by modulating NF-kB-mediated
inflammatory responses.44 Ginseng inhibited colonic inflammation
and tumorigenesis promoted by Western diet, and Compound K
appears to contribute to the chemopreventive effects of ginseng on
colonic tumorigenesis.37
In summary, KRG prevented colitis-induced induced colon
carcinogenesis by blocking activation of NF-kB and STAT3 and
overexpression of their target proteins (Fig. 7). Anti-carcinogenic
activity of KRG results from the inhibition of colitis which is a
prerequisite for promotion of colon carcinogenesis. Therefore, KRG
is a potential candidate for chemoprevention of inflammation-
associated colon carcinogenesis.
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